Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Express Scripts
Colorcon
Baxter
UBS
Farmers Insurance
US Department of Justice
Johnson and Johnson
Covington

Generated: August 17, 2018

DrugPatentWatch Database Preview

Dorc Company Profile

« Back to Dashboard

What is the competitive landscape for DORC, and what generic alternatives to DORC drugs are available?

DORC has two approved drugs.

There are two US patents protecting DORC drugs.

There are thirty-one patent family members on DORC drugs in fourteen countries.

Summary for Dorc
International Patents:31
US Patents:2
Tradenames:2
Ingredients:1
NDAs:2

Drugs and US Patents for Dorc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dorc MEMBRANEBLUE trypan blue SOLUTION;OPHTHALMIC 022278-001 Feb 20, 2009 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial
Dorc VISIONBLUE trypan blue SOLUTION;OPHTHALMIC 021670-001 Dec 16, 2004 RX Yes Yes 6,720,314 ➤ Try a Free Trial ➤ Try a Free Trial
Dorc VISIONBLUE trypan blue SOLUTION;OPHTHALMIC 021670-001 Dec 16, 2004 RX Yes Yes 6,367,480 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Non-Orange Book US Patents for Dorc

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,696,430 Use of vital dye for facilitating surgical procedures for vitreo-retinal surgery ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Dorc Drugs

Country Document Number Estimated Expiration
Brazil 9910288 ➤ Try a Free Trial
Denmark 1075285 ➤ Try a Free Trial
Australia 758951 ➤ Try a Free Trial
European Patent Office 1075284 ➤ Try a Free Trial
Japan 3469198 ➤ Try a Free Trial
European Patent Office 0963759 ➤ Try a Free Trial
Austria 232400 ➤ Try a Free Trial
Country Document Number Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Federal Trade Commission
Julphar
Argus Health
Chinese Patent Office
Baxter
US Army
Farmers Insurance
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.